home About Us People Portfolio Contact Us Fund II Investor Login » Fund III Investor Login » Fund IV Investor Login » Fund V Investor Log In »

Intrinsic Therapeutics

$29 million

Medical Device

Intrinsic Therapeutics is a medical device company focused on delivering a safe treatment to improve efficacy in patients who are at a disproportionately high risk of requiring repeat surgeries due to reherniation following a lumbar discectomy surgery. The Barricaid bone-anchored annular closure device received FDA PMA-approval following completion of a 554-patient randomized controlled trial that achieved superiority at two years. Survival analyses have indicated statistical significance in reducing reherniations and reoperations through five years. See http://www.barricaid.com for complete benefit-risk information.